Release Date: 23/03/16 12:07 Summary: Variation of Takeover Bid - Extension of Offer Period Price Sensitive: Yes Download Document 131.64KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%